chrisvoncsefalvay/vaers-outcomes huggingface dataset:
24 Mar 98 deployed to Africa. 16 Feb 99 reported passing out and losing bladder control. Referred for radiology and neurology consult. 23 Feb 99 Mri done, normal. 11 Mar 99 Consult w/neurosurgeon. Possibility of partial seizure. Refer for EEG. 2 Apr 99 EEG done, normal. 8 Apirl 99 Cardiology consult with tilt study done. Failed tilt test. 7 May 99, stress echocardiogram performed results pending. Anthrax vaccination dates #1 9/22/98, #2 10/23/98, #3 11/12/98
Pfizer bivalent booster dose given as first dose of primary series, rather than monovalent dose.
I received the first dose on Thursday the 24th, my appointment was at 12:00pm at Urgent Care. I felt some soreness in my neck Friday the 25th but didnt think much of it. The next day, Saturday 26th, my neck was completely tense with horrible pain when trying to turn my neck, especially to the right.   My wife received the vaccine at the same time I did and she is also experiencing the same neck issue as me, we found it strange that both of use are having the same pain after receiving the vaccine and decided to report this issue.  It is now 4 days later and the pain is still present along with limited range of motion.
4/9/2018 left arm pain and redness, painful to the touch. On 4-12-18 rash on neck and right side of face appeared. Patient went to PCP who instructed her to take BENADRYL and go to eye doctor. Eye doctor said there was no eye involvement, that she was ok.
This case was reported by a nurse via sales rep and described the occurrence of shingles in a female patient who received Shingrix for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The patient presented with shingles within 3 days of receiving the vaccine. It was not clear that which patient out of 3 has not received vaccine in reported pharmacy, the pharmacy name is not coded. This case has been linked with US2018GSK173217 and US2018GSK173211, reported by the same reporter.
pt recv SEP95 & approx NOV97 pt was exposed to natural varicella @ school & broke out w/chicken pox consisting of 30 to 40 lesions or 50 to 100 lesions;17NOV97 pt had recovered;
Headache, fatigue, light-headed feeling, bruising on arm for 2 weeks.
Information has been received from a female patient of unknown age referring to herself. Information about medical history, concurrent condition and concomitant medication was not reported. On 14-APR-2014 the patient was given a dose of GARDASIL (the first dose, route: injection; strength, lot#, dosage and frequency unspecified) instead of a hepatitis B vaccine (manufacturer unknown). No adverse events occurred. Additional information is not expected because no contact details were available.
Tinnitus, vertigo, dizziness started within less than a week after injection, continues to this date. There was also low grade fever and malaise for about 12 hours starting within 24 hours of injection, and subsequently subsided.
when woke up today 4/27/21 at 7am, exhausted, muscle ache, headache, fever 101.3, foggy brain, 2 new symptoms that I didn't get with first vaccine: VERY thirsty, bloodshot eyes
Tremor; constantlyThirsty; Nausea; Joint pain; Pain in arm; Chills; Headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of THIRST (constantlyThirsty), PAIN IN EXTREMITY (Pain in arm), TREMOR (Tremor), CHILLS (Chills) and HEADACHE (Headache) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B(UA)) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL, SIMVASTATIN and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (fatigue). On 17-Apr-2021, the patient experienced THIRST (constantlyThirsty), TREMOR (Tremor), NAUSEA (Nausea) and ARTHRALGIA (Joint pain). On 17-Apr-2021, PAIN IN EXTREMITY (Pain in arm), HEADACHE (Headache) and FATIGUE (fatigue) had resolved. On 18-Apr-2021, THIRST (constantlyThirsty), TREMOR (Tremor), CHILLS (Chills), NAUSEA (Nausea) and ARTHRALGIA (Joint pain) had resolved.            Treatment drug: PARACETAMOL taken by the patient .   This case was linked to US-MODERNATX, INC.-MOD-2021-080414 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080414:FIRST DOSE
Several hours after my second dose of the Pfizer Covid-19 vaccine, I was lying in bed, flat on my back, winding down for sleep when, suddenly, my right leg was seized by sudden nerve pain in my calf, simultaneous with severe muscle cramping in my quadricep.  I also started experiencing sharp nerve "zaps" throughout my entire body--arms, legs, hands, feet, and face primarily. It took several days for the nerve pains to cease, but, two months later, I still have the nerve pains occurring in my face. I think that the facial pain is related to a prior condition of post-herpetic neuralgia from the cold sore virus (HSV1), even though I hadn't had an outbreak in several months before getting the second dose. The other symptoms, though, including the muscle cramping and severe stiffness, as well as the shooting nerve pain in my limbs, were all brand new, beginning for the first time in the hours after my second Pfizer vaccine.  For the next one-to-two weeks after my second dose, my right leg and, to some extent, the left leg, had severe, frightening stiffness that I had never experienced in my life.  It was even a little difficult to walk, and walking slowly exacerbated the stiffness. I had NOT been exercising in the days before these symptoms began. The only new activity in my life had been that I'd gotten the Pfizer vaccine, so I went to my primary physician to report my symptoms a few days after they began, and she was concerned. She suggested that I stretch my muscles regularly, which I tried, and it made absolutely zero impact or improvement in my muscular stiffness. I just had to wait for the symptoms to subside on their own, which, thankfully, occurred. I firmly believe that the Pfizer vaccine caused the stiffness, cramping, and nerve pain, and I truly hope that a booster shot is  not needed in the future because I would think pretty hard about whether to get it. I would worry about developing permanent nerve and muscular problems as a results of a third dose.
Two days post vax pt developed red rash/hives over back to hairline. The next day pt had hives on neck and chest. Pt seen in ER and treated with steroids.
injection site pain; injection site swelling; injection site redness; rash on arm of injection; joint pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 19May2021 09:00 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "allergy dog dander, cats," (unspecified if ongoing), notes: Known allergies: Yes, dog dander, cats, strawberry, dust, citrus fruits; "allergy strawberry, citrus fruits" (unspecified if ongoing), notes: Known allergies: Yes, dog dander, cats, strawberry, dust, citrus fruits; "allergy dust" (unspecified if ongoing), notes: Known allergies: Yes, dog dander, cats, strawberry, dust, citrus fruits. The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 09Jun2021 19:00, outcome "recovering", described as "injection site pain"; VACCINATION SITE SWELLING (non-serious) with onset 09Jun2021 19:00, outcome "recovering", described as "injection site swelling"; VACCINATION SITE ERYTHEMA (non-serious) with onset 09Jun2021 19:00, outcome "recovering", described as "injection site redness"; VACCINATION SITE RASH (non-serious) with onset 09Jun2021 19:00, outcome "recovering", described as "rash on arm of injection"; ARTHRALGIA (non-serious) with onset 09Jun2021 19:00, outcome "recovering", described as "joint pain". Therapeutic measures were not taken as a result of vaccination site pain, vaccination site swelling, vaccination site erythema, vaccination site rash, arthralgia.  Additional information: Adverse events were also reported after the second dose of vaccine administered on 09Jun2021 at 9 AM. At 07PM on 10Jun2021, patient had Fever, body ache, head ache, tiredness and no appetite. Stop date of events were 12Jun2021. It was unknown if the Patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19, since the vaccination, patient has not been tested for COVID-19. Lot number was unknown as it was unable to locate or read the details.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pain on the left arm; Swelling on the left arm; Injected on the left forearm; This is a spontaneous report from a contactable consumer.  A female patient of unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, Lot #: X90022), via an unspecified route of administration on the left forearm arm on an unspecified date at single dose for immunization.  The patient's medical history and concomitant medications were not reported. The patient was injected 1 vaccine of pneumococcal 13-val conj vac (dipht crm197 protein) on the left forearm arm and she returned days after claiming pain and swelling on the left arm on 16Mar2019 since the date vaccine was administered. The outcome of the events was unknown.
My booster was on Monday 10/25 and I felt great that day and Tuesday, but Wednesday night at 9-10PM, I realized had a really sore throat, but I went to bed and didn't sleep really well. I had aches and pains. When I got up, I took my temperature, and it was 100.00. I was achy, etc. My throat was really sore. I took a flashlight and looked at my throat. And I had 5-6 white spots or sores on my tonsils on the left side. It was very tender underneath my jaw. So I spent that day (Thursday) not feeling good. I took ibuprofen during the day and rested and drank fluids. I thought if I didn't feel good the next day, I would go see the doctor. I still felt crummy but I wasn't running a fever the next day but my throat still hurt. Hurt to talk and swallow. I went to  see my doctor, he did a COVID-19 test which was negative, and he prescribed Dexamethasone and I was required to swish it around and swallow it and do that for 3-5 days. I've taken it for 3 days, and I didn't take any today. I do still feel raspy, and I still have the spots on my tonsil, but it isn't painful anymore. And my doctor put down on the diagnosis that it was an upper respiratory tract infection of unspecified type. Feeling back to normal now.
After about 5-10 minutes after receiving the vaccine, patient stated that her arm started to feel like it was becoming swollen. Patient was monitored and Benadryl and EpiPens were prepared. Patient wanted to take the Benadryl and took 2 25mg caps. Patient had not eaten or drank anything prior to shot and water was provided. Pt became nauseas and described chest tightness and threw up both Benadryl caps as well as the small amount of water that she drank. BP ~160/110, HR: 65 after vomiting. EMS services arrived,  and the patient was brought to the hospital for further evaluation
The morning after receiving the 1st dose of the Pfizer COVID-19 vaccine, I noticed redness and inflammation at the injection site. The next day (48hrs following the injection) the redness and inflammation grew in diameter on my arm. I am not sure if it is related, but it feels like I am also having troubles regulating my body temperature (hot/cold waves).
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, chills, arm pain Narrative:
Loss sense of smell; This spontaneous case was reported by a pharmacist and describes the occurrence of ANOSMIA (Loss sense of smell) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced ANOSMIA (Loss sense of smell). At the time of the report, ANOSMIA (Loss sense of smell) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Pt was positive for COVID in October 2020.  Pt received both doses of COVID Moderna vaccine as noted above.  Pt became symptomatic again on 03/23 and tested positive for COVID again on 03/24/21.
Patient received Shingrix  shot on 5-19-2019 at 1:30pm and experienced pain at the injection site and later had a temp of 100.2. Later in the day around 5:30pm she had swelling and was unable to move her arm. It was hot even after applying ice. The area affected was where shot was given, but over time has moved down the arm. Patient saw her DR. on 5-22-2019 and received Doxycycline 100mg twice daily for 10 days. She will follow up with her DR. on 05-23-2019
back pain; little sick in her stomach; headaches in the front of her head; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain), NAUSEA (little sick in her stomach) and HEADACHE (headaches in the front of her head) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 039A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BACK PAIN (back pain), NAUSEA (little sick in her stomach) and HEADACHE (headaches in the front of her head). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Back ache, at an unspecified dose and frequency. At the time of the report, BACK PAIN (back pain), NAUSEA (little sick in her stomach) and HEADACHE (headaches in the front of her head) outcome was unknown. Not Provided          No relevant concomitant medications were reported.
Patient was scheduled to receive her 2nd dose of Moderna Monovalent in her primary Covid 19 vaccination series and was accidentally given Moderna Bivalent
A lymph node on the base of my neck on the left side swelled painfully.  The lymph node is tender to the touch. It does not hurt when it is not touched, but when touched the pain level is about a 4. Today is day 2 of the painful swelling. I have never experienced swelling or pain in this particular lymph node before.
2 hours post vaccination, shortness of breath, rapid heart rate, dizziness, wide spread hives, nausea and intense headache. Diphenhydramine and famotidine were used and epi pen considered but not needed.
Client received 1st dose of Moderna vaccine at 1305. At 1320 client reported it "feels hard to swallow." Client was also experiencing dizziness, and tongue numbness. Client VS at 1320 were O2 93% on room air, P 90, BP 190/102, and R 16. Client did not experience any SOB or difficulty breathing.  Client had no visible swelling or hives. Client reports "being worked up about this all day" in regards to getting her vaccine. Client has HTN and is on medication, but reports drinking "12 cups of extra strong coffee and 1 Mtn. Dew" before getting her vaccination. Client BP at 1330 was 170/90 and at 1335 168/90. At 1330 client reports difficulty swallowing and tongue numbness had resolved. Client was kept on continuous pulse oximetry until symptoms resolved. Client advised to follow up with her PCP in regards to elevated BP.  Client saw Dr. on 4/1/21 in regards to her BP and symptoms following vaccination.  Per client her BP was 122/70 at her office visit. Client states that Dr. said it was okay to get her 2nd dose in 4 weeks, but that client "should lay off of the caffeine."
Dizziness; Ache all over; Fever; Sick to point of vomiting; Sick to point of vomiting; This is a spontaneous report from a contactable consumer, the patient. An 83-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm left on 19Mar2021 at 13:00 (at the age of 83-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EB8733) via an unspecified route of administration in the arm left on 14Apr2021 (at the age of 83-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy (all sulphur drugs) and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had been tested for COVID-19. On 19Mar2021 at 15:30, on the first vaccine, the patient experienced dizziness, ache all over, fever, sick to point of vomiting. This lasted three and half days. Exact same reaction to second shot but only one and half days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date post vaccination, the patient underwent COVID-19 nasal swab test and the result was negative. The clinical outcome of the events dizziness, ache all over, fever, sick to point of vomiting were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
She got high blood pressure after receiving the second COVID shot which was Moderna vaccine; This spontaneous case was reported by a patient and describes the occurrence of HYPERTENSION (She got high blood pressure after receiving the second COVID shot which was Moderna vaccine) in an 83-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (She got high blood pressure after receiving the second COVID shot which was Moderna vaccine). At the time of the report, HYPERTENSION (She got high blood pressure after receiving the second COVID shot which was Moderna vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: High blood pressure.         No concomitant product reported by reporter.  No treatment medication reported by reporter.
1 of 8 pt (4-6 yr old range) seen /win the past wk /w severe local rxns.  Pt has 3 X 2 inch area of redness, tenderness & warmth, also had low fever.
small erythemic vesicles on chin, trunk & arms;no papules seen 12:00 29APR99;afeb, HEENT WNL, chest clear, no wheezes, heart RRR 5;
pt recvd vax & w/in 24hrs post vax felt unwell;sx were muscle & joint aches,pain in the cervical area,migraine,& low grade fever;these sx gradually inc over 48hrs to severe intensity;pt was seen by MD:sx persist
Patient developed hemorrhagic shock w/ encephalopathy syndrome 5 days after vaccine administration and died.  1/27/2009 MR received for DOS 12/16-18/2008 which was the Date of death. Principal DX:  Multisystem organ failure 2' to Hemorrhagic Shock and Encephalopathy Syndrome (HSES). Pt initially presented with new onset seizures and diarrhea. Pt in usual state of good health a.m. of 1/16/09 except for some recent mild congestion. Later noted to be sweaty and did not respond while parent was changing clothes. Later noted to be eye rolling and making unusual movements.  In status epilepticus and metabolic acidosis on arrivial in local ED.  Intubated and medicated for seizures and transferred to higher level of care. Cool and mottled on arrival. LFTs elevated. Issues with hypoglycemia, abnormal coags  and electrolyte fluctuations with little response to tx. Parents elected to withdraw life support follwing notification of fatal status of illness. 2/12/09 Death Cert received.  COD- Multiorgan Failure.  Hemorrhagic Shock and Encephalopathy Syndrome.
SUSPECTED IMMUNOLOGICAL VACCINE FAILURE; This spontaneous report received from a patient a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total dose administered on 05-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, patient got tested for antibodies (specifically antibodies to the spike protein) for travel purposes. The patient's other option was to got a negative covid-19 test. As per the patient, the antibody test was valid for 4 months while negative covid-19 test was only valid for 5 days from travel. Patient opted for antibody testing. Test for covid-19 vaccine antibodies came back negative. So, patient did not had antibodies to the spike protein. The patient tested for S1-RBD Antibodies (S), or worse case scenario patient did not develop antibodies to the spike protein. The action taken with covid-19 vaccine was not applicable. The outcome of suspected immunological vaccine failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: covid-19 vaccine. Suspected immunological vaccine failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
NASAL CONGESTION, FACIAL PRESSURE, LOSS OF SMELL, FATIGUE
Hematuria with gross hematuria with onset a few hours after administration - no other symptoms. Grossly improved after 48 hours.
swelling bumps; rash; redness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), SWELLING (swelling bumps) and RASH (rash) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L00A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced ERYTHEMA (redness). On 24-Jan-2021, the patient experienced SWELLING (swelling bumps) and RASH (rash). On 26-Jan-2021, SWELLING (swelling bumps) and RASH (rash) had resolved. At the time of the report, ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided
Woke up this morning with itchy rash on my arm. Rash quickly spread from one arm to the other arm to my torso, neck, head and legs. Took benedryl symptoms went away. As soon as benedryl started to wear off the symptoms started coming back. Hives on arm and neck.